BioMarin Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
14.07.25
/
50%
€50.32
Target price
14.07.26
€96.68
Performance (%)
-3.95%
Price
18.03.26
€48.33
Summary
This prediction is currently active. With a performance of -3.95%, the BUY prediction for BioMarin Pharmaceutical Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 14.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -7.272% | -7.272% |
| iShares Core DAX® | -2,12 % | -8,18 % |
| iShares Nasdaq 100 | -1,13 % | 0,91 % |
| iShares Nikkei 225® | -0,66 % | -6,26 % |
| iShares S&P 500 | -1,26 % | -1,00 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at JPMorgan Chase & Co. from $108.00 to $113.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.83
09.10.25
09.10.25
€102.23
09.10.26
09.10.26
3.20%
18.03.26
18.03.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€61.40
30.10.24
30.10.24
€100.36
30.10.25
30.10.25
-26.91%
31.10.25
31.10.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€108.11
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25